Hospital Ruber Internacional   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Madrid Spain (1942)

Organization Overview

First Clinical Trial
2004
NCT00957372
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Hospital Ruber Internacional | Hospital Ruber Internacional La Masó 38, Mirasierra 28034 Madrid, Spain | Rúber Internacional Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

fenfluramine (Pondimin) (1 trial)

Drugs in Phase 3 Trials (1)

eslicarbazepine acetate (aptiom) (1 trial)

Drugs in Other Trials (1)

Galactose (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Epilepsies, Partial (Phase 3)

Epilepsy (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3